HomeCompareHZRZF vs MRK

HZRZF vs MRK: Dividend Comparison 2026

HZRZF yields 28.21% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HZRZF wins by $62.5K in total portfolio value
10 years
HZRZF
HZRZF
● Live price
28.21%
Share price
$7.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.3K
Annual income
$14,958.51
Full HZRZF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — HZRZF vs MRK

📍 HZRZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHZRZFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HZRZF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HZRZF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HZRZF
Annual income on $10K today (after 15% tax)
$2,397.51/yr
After 10yr DRIP, annual income (after tax)
$12,714.73/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, HZRZF beats the other by $4,386.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HZRZF + MRK for your $10,000?

HZRZF: 50%MRK: 50%
100% MRK50/50100% HZRZF
Portfolio after 10yr
$88.0K
Annual income
$12,378.33/yr
Blended yield
14.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HZRZF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HZRZF buys
0
MRK buys
0
No recent congressional trades found for HZRZF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHZRZFMRK
Forward yield28.21%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$119.3K$56.8K
Annual income after 10y$14,958.51$9,798.13
Total dividends collected$79.5K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HZRZF vs MRK ($10,000, DRIP)

YearHZRZF PortfolioHZRZF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,521$2,820.60$11,206$366.19+$2.3KHZRZF
2$18,031$3,564.13$12,650$502.35+$5.4KHZRZF
3$23,736$4,442.19$14,407$694.19+$9.3KHZRZF
4$30,862$5,464.98$16,585$967.82+$14.3KHZRZF
5$39,663$6,640.94$19,342$1,363.89+$20.3KHZRZF
6$50,416$7,976.47$22,913$1,947.19+$27.5KHZRZF
7$63,421$9,475.63$27,662$2,823.89+$35.8KHZRZF
8$79,000$11,140.05$34,159$4,173.35+$44.8KHZRZF
9$97,499$12,968.82$43,337$6,308.80+$54.2KHZRZF
10$119,283$14,958.51$56,776$9,798.13+$62.5KHZRZF

HZRZF vs MRK: Complete Analysis 2026

HZRZFStock

The fund seeks investment results that correspond to 2x inverse of the daily performance of its underlying index, which is designed to measure the performance of Canadian companies active in the gold mining industry and are classified as producers of gold and gold-related products. The fund is market-cap-weighted, with individual constituents capped at 25% of the index weight. As a levered fund, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.

Full HZRZF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HZRZF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HZRZF vs SCHDHZRZF vs JEPIHZRZF vs OHZRZF vs KOHZRZF vs MAINHZRZF vs JNJHZRZF vs ABBVHZRZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.